跳至主要内容
临床试验/CTRI/2017/09/009743
CTRI/2017/09/009743已完成3 期

Comparison of the efficacy of a 7-day versus a 14-day course of intravenous antibiotics in the treatment of uncomplicated neonatal bacterial sepsis: a randomized controlled non-inferiority trial

Indian Council of Medical Research0 个研究点目标入组 261 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
261

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria for the initial observational period:
  • 1. Neonates aged 0-28 days, either inborn or outborn, who are currently admitted in the Neonatal unit of the centre,
  • 2. Whose birth weight is greater than 1500 grams (it should be reliably ascertained from records of a hospital),
  • 3. Whose residence is within approximately 15 kms from the centre, so that the infant can be brought back to the centre for follow up.
  • 4. Who have suspected septicemia for which a conventional or BACTEC/BACTALERT blood culture is sent and for which the treating physician decides to start antibiotics
  • Randomization criteria applicable after 7 days of therapy of above patients with sensitive antibiotics:
  • 1.Positive blood culture other than Staphylococcus aureus
  • 2.No signs and symptoms of sepsis from end of day 5 through end of day 7 of starting sensitive antibiotics (This will be on day 5 through 7 for those who have improved and will be, for instance, day 8 through 10 for those whose initial empiric antibiotics were resistant requiring a change in antibiotic on day 3 of enrollment)

排除标准

  • Exclusion criteria for the initial observational period:
  • 1. Central Nervous System infection (meningitis will be defined as one or more of CSF cell count >= 25 per microliter with > 60% neutrophils; glucose <20 mg/dl or CSF: blood glucose <0.6 or protein >150 mg/dL in term or >180 mg/dL in preterm or positive gram stain report)
  • 2. Septic arthritis, osteomyelitis or deep-seated abscess as clinically judged by the treating team
  • 3. Life threatening congenital malformations as judged by the principal investigator of the centre
  • Exclusion criteria for randomization applicable after 7 days of therapy of above patients with sensitive antibiotics:
  • 1. Sterile blood culture
  • 2. Suspected contaminants in blood culture.
  • 3. Growth of Staphylococcus aureus in blood culture
  • 4. Growth of fungal organism in blood culture
  • 5. Diagnosis of meningitis, septic arthritis, osteomyelitis, abscess
  • 6. Has not gone into remission on day 5 or have recurrence of symptoms from day 5 through day 7
  • 7. If the empiric antibiotic is resistant but neonate has shown improvement of signs and symptoms of sepsis and there is ambiguity regarding in vivo sensitivity of antibiotic use

研究者

相似试验